35 results were returned
International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...
International law firm Bird & Bird today boosts its Corporate practice with the appointment of life sciences expert Michiel Wurfbain as a partner in The Hague.
Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
International law firm Bird & Bird advised global safety equipment manufacturer MSA Safety Incorporated (NYSE: MSA) on the acquisition of U.K.-based Bristol Uniforms (“Bristol”) in an all-cash transaction valued at ...
Bird & Bird LLP has advised Pfizer on the global spin-off and merger of its Upjohn business with Mylan N.V. to form the new global pharmaceutical company with the name Viatris Inc.
The Swedish listed company AddLife AB is a market leading player within Life Science offering quality products and advice to both the private and the public sectors, primarily in the Nordics and the rest of Europe.
International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy
European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...